Celldex Therapeutics Quarterly Balance Sheets Chart
Quarterly
|
Annual
Celldex Therapeutics Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-09-30 | 2004-06-30 | 2004-03-31 | 2003-09-30 | 2003-06-30 | 2003-03-31 | 2002-09-30 | 2002-03-31 | 2001-09-30 | 2001-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 23,044,000 | 17,136,000 | 28,356,000 | 36,399,000 | 42,739,000 | 115,077,000 | 34,814,000 | 21,134,000 | 28,224,000 | 54,123,000 | 29,429,000 | 18,583,000 | 28,401,000 | 25,293,000 | 39,143,000 | 72,184,000 | 43,446,000 | 69,313,000 | 43,836,000 | 18,151,000 | 68,027,000 | 22,724,000 | 16,586,000 | 19,744,000 | 31,533,000 | 32,823,000 | 43,894,000 | 39,824,000 | 54,735,000 | 66,162,000 | 42,497,000 | 31,743,000 | 32,482,000 | 63,025,000 | 66,791,000 | 81,584,000 | 122,170,000 | 32,525,000 | 40,797,000 | 56,902,000 | 14,626,000 | 25,900,000 | 75,627,000 | 23,187,000 | 18,563,000 | 22,755,000 | 13,097,000 | 10,830,000 | 10,140,000 | 9,828,000 | 15,158,000 | 42,666,000 | 25,985,000 | 31,633,000 | 39,364,362 | 42,697,228 | 52,379,836 | 11,418,544 | 20,339,659 | 25,909,541 | 32,573,796 | 40,911,539 | 46,681,330 | 53,468,716 | 59,755,919 | 23,419,434 | 22,198,775 | 27,028,598 | 27,309,120 | 35,228,300 | 39,370,700 | 41,161,500 | 23,498,400 | 16,984,100 | 19,750,400 | 26,314,000 | 37,054,200 | 34,736,900 | 40,706,000 |
| marketable securities | 607,293,000 | 656,155,000 | 696,925,000 | 719,600,000 | 759,578,000 | 708,769,000 | 388,784,000 | 214,214,000 | 224,473,000 | 224,264,000 | 275,523,000 | 304,888,000 | 328,416,000 | 355,175,000 | 369,107,000 | 350,905,000 | 120,591,000 | 106,770,000 | 150,586,000 | 181,443,000 | 138,888,000 | 30,998,000 | 56,332,000 | 61,598,000 | 53,535,000 | 72,795,000 | 70,115,000 | 83,424,000 | 85,795,000 | 87,822,000 | 124,526,000 | 171,505,000 | 187,646,000 | 190,992,000 | 237,819,000 | 252,408,000 | 237,603,000 | 191,553,000 | 211,572,000 | 217,324,000 | 121,962,000 | 129,083,000 | 106,750,000 | 54,428,000 | 60,109,000 | 69,374,000 | 49,677,000 | 60,406,000 | 34,167,000 | 47,829,000 | 50,674,000 | 32,700,000 | |||||||||||||||||||||||||||
| accounts and other receivables | 90,000 | 1,064,000 | 700,000 | 852,000 | 1,534,000 | 2,671,000 | 2,628,000 | 252,000 | 118,000 | 1,314,000 | 347,000 | 189,000 | 97,000 | 243,000 | 172,000 | 197,000 | 496,000 | 1,828,000 | 1,802,000 | 838,000 | 329,000 | 1,108,000 | 727,000 | 1,170,000 | 2,307,000 | 3,175,000 | 3,423,000 | 4,020,000 | 3,013,000 | 1,359,000 | 1,384,000 | 1,579,000 | 1,116,000 | 847,000 | 527,000 | 434,000 | 679,000 | 2,905,000 | 525,000 | 305,000 | 890,000 | 12,000 | 104,000 | 32,000 | 61,000 | 140,000 | 204,000 | 163,000 | 243,000 | 456,000 | 738,000 | 859,000 | 1,091,000 | 1,013,000 | 1,077,107 | 11,481,828 | 1,538,044 | 176,072 | 525,600 | ||||||||||||||||||||
| prepaid and other current assets | 17,977,000 | 19,402,000 | 21,178,000 | 21,991,000 | 8,124,000 | 8,807,000 | 5,467,000 | 10,333,000 | 12,005,000 | 9,896,000 | 12,394,000 | 10,939,000 | 11,065,000 | 9,988,000 | 2,417,000 | 3,269,000 | 3,073,000 | 3,588,000 | 1,619,000 | 2,493,000 | 1,748,000 | 1,088,000 | 1,458,000 | 1,853,000 | 1,476,000 | 2,176,000 | 2,848,000 | 3,704,000 | 3,774,000 | 4,709,000 | 5,056,000 | 4,887,000 | 7,538,000 | 6,091,000 | 4,119,000 | 5,115,000 | 3,677,000 | 2,842,000 | 2,703,000 | 2,288,000 | 2,468,000 | 1,435,000 | 1,972,000 | 1,163,000 | 1,665,000 | 1,967,000 | 1,404,000 | 1,890,000 | 1,678,000 | 1,087,000 | 1,681,000 | 2,058,000 | 934,000 | 863,000 | 1,397,361 | 1,171,014 | 767,082 | ||||||||||||||||||||||
| total current assets | 648,404,000 | 693,757,000 | 747,159,000 | 778,842,000 | 811,975,000 | 835,324,000 | 431,693,000 | 245,933,000 | 264,820,000 | 289,597,000 | 317,693,000 | 334,599,000 | 367,979,000 | 390,699,000 | 410,839,000 | 426,555,000 | 167,606,000 | 181,499,000 | 197,843,000 | 202,925,000 | 208,992,000 | 55,918,000 | 75,103,000 | 84,365,000 | 88,851,000 | 110,969,000 | 120,280,000 | 130,972,000 | 147,317,000 | 160,052,000 | 173,463,000 | 209,714,000 | 228,782,000 | 260,955,000 | 309,256,000 | 339,541,000 | 364,129,000 | 229,825,000 | 255,597,000 | 276,819,000 | 139,946,000 | 156,430,000 | 184,453,000 | 78,810,000 | 80,398,000 | 94,236,000 | 64,382,000 | 73,289,000 | 46,228,000 | 59,200,000 | 68,251,000 | 78,283,000 | 28,010,000 | 33,509,000 | 41,838,830 | 55,560,730 | 69,025,814 | 22,676,922 | 21,380,377 | 27,329,094 | 33,924,551 | 42,403,494 | 48,162,887 | 54,992,315 | 61,249,898 | 24,604,896 | 28,592,909 | 33,088,810 | 28,894,316 | 36,614,800 | 40,201,100 | 43,443,800 | 24,781,800 | 18,035,000 | 20,971,400 | 29,144,600 | 37,762,300 | 35,912,200 | 42,411,600 |
| property and equipment | 4,392,000 | 4,601,000 | 4,346,000 | 4,230,000 | 3,864,000 | 4,061,000 | 4,060,000 | 4,162,000 | 3,938,000 | 3,995,000 | 3,747,000 | 3,753,000 | 3,744,000 | 3,484,000 | 3,551,000 | 3,342,000 | 3,496,000 | 3,747,000 | 3,815,000 | 3,813,000 | 4,044,000 | 4,116,000 | 4,488,000 | 5,086,000 | 5,462,000 | 6,699,000 | 7,478,000 | 9,785,000 | 11,308,000 | 12,069,000 | 12,411,000 | 11,355,000 | 11,293,000 | 11,392,000 | 11,864,000 | 11,735,000 | 11,236,000 | 10,716,000 | 10,601,000 | 10,216,000 | 8,814,000 | 7,338,000 | 7,131,000 | 7,566,000 | 7,998,000 | 8,447,000 | 9,539,000 | 9,985,000 | 10,472,000 | 10,924,000 | 10,972,000 | 10,965,000 | 12,015,000 | 12,551,000 | 13,015,741 | 14,190,971 | 14,033,088 | 14,592,563 | 17,072,700 | 16,555,004 | 15,551,013 | 13,967,800 | 10,534,372 | 7,950,494 | 6,203,757 | 5,743,663 | 5,119,239 | 4,788,560 | 4,430,436 | 2,171,700 | 1,113,200 | 1,053,100 | 972,900 | 1,068,700 | 1,114,000 | 1,038,200 | 1,029,000 | 1,084,000 | 977,100 |
| operating lease right-of-use assets | 3,121,000 | 3,514,000 | 3,898,000 | 3,170,000 | 2,450,000 | 2,165,000 | 2,577,000 | 2,864,000 | 3,256,000 | 3,633,000 | 4,001,000 | 3,580,000 | 3,944,000 | 2,564,000 | 2,970,000 | 3,016,000 | 2,718,000 | 3,088,000 | 3,449,000 | 3,801,000 | 3,134,000 | 3,739,000 | 3,431,000 | 3,974,000 | 4,445,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| intangible assets | 27,190,000 | 27,190,000 | 27,190,000 | 27,190,000 | 27,190,000 | 27,190,000 | 27,190,000 | 27,190,000 | 27,190,000 | 27,190,000 | 27,190,000 | 27,190,000 | 27,190,000 | 27,190,000 | 27,190,000 | 27,190,000 | 30,690,000 | 30,690,000 | 30,690,000 | 45,190,000 | 45,190,000 | 48,690,000 | 48,690,000 | 48,690,000 | 48,690,000 | 48,690,000 | 48,690,000 | 48,690,000 | 67,815,000 | 81,039,000 | 81,263,000 | 20,034,000 | 20,287,000 | 20,541,000 | 21,047,000 | 21,300,000 | 21,554,000 | 22,060,000 | 22,313,000 | 22,567,000 | 23,073,000 | 23,326,000 | 23,580,000 | 24,087,000 | 24,340,000 | 24,632,000 | 25,214,000 | 25,870,000 | 26,353,000 | 27,319,000 | 27,801,000 | 28,459,000 | 1,941,000 | 2,036,000 | 2,131,623 | 2,576,414 | 2,680,388 | 2,784,552 | |||||||||||||||||||||
| other assets | 9,300,000 | 10,409,000 | 9,747,000 | 9,747,000 | 107,000 | 107,000 | 107,000 | 107,000 | 107,000 | 104,000 | 104,000 | 104,000 | 104,000 | 104,000 | 104,000 | 98,000 | 41,000 | 41,000 | 41,000 | 41,000 | 41,000 | 41,000 | 129,000 | 129,000 | 129,000 | 1,929,000 | 1,929,000 | 1,929,000 | 2,002,000 | 1,935,000 | 1,935,000 | 1,879,000 | 1,879,000 | 78,000 | 1,500,000 | 1,676,000 | 1,816,000 | 99,000 | 116,000 | 132,000 | 157,000 | 174,000 | 236,000 | 409,000 | 428,000 | 460,000 | 348,000 | 367,000 | 386,000 | 5,401,000 | 5,582,000 | 5,773,000 | 6,136,000 | 6,316,000 | 6,496,643 | 6,857,420 | 262,767 | 262,099 | |||||||||||||||||||||
| total assets | 692,407,000 | 739,471,000 | 792,340,000 | 823,179,000 | 845,586,000 | 868,847,000 | 465,627,000 | 280,256,000 | 299,311,000 | 324,519,000 | 352,735,000 | 369,226,000 | 402,961,000 | 424,041,000 | 444,654,000 | 460,201,000 | 204,551,000 | 219,065,000 | 235,838,000 | 255,770,000 | 261,401,000 | 112,504,000 | 131,841,000 | 142,244,000 | 147,577,000 | 168,287,000 | 178,377,000 | 191,376,000 | 319,418,000 | 346,071,000 | 360,048,000 | 251,947,000 | 271,206,000 | 301,931,000 | 352,632,000 | 383,217,000 | 407,700,000 | 271,665,000 | 297,592,000 | 318,699,000 | 180,955,000 | 196,233,000 | 224,365,000 | 119,837,000 | 122,129,000 | 136,740,000 | 108,448,000 | 118,476,000 | 92,404,000 | 111,809,000 | 121,571,000 | 132,445,000 | 48,102,000 | 54,412,000 | 63,482,837 | 79,185,535 | 86,342,637 | 40,803,760 | 43,404,629 | 49,209,200 | 54,343,763 | 61,479,542 | 64,054,284 | 68,548,612 | 73,308,236 | 36,451,917 | 40,064,284 | 44,478,284 | 40,174,444 | 46,133,800 | 48,900,100 | 52,331,400 | 35,171,800 | 28,781,900 | 32,019,900 | 38,689,900 | 47,725,400 | 46,578,000 | 53,344,000 |
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable | 2,073,000 | 3,410,000 | 3,265,000 | 1,114,000 | 3,802,000 | 3,234,000 | 3,494,000 | 3,586,000 | 881,000 | 3,374,000 | 3,340,000 | 2,272,000 | 902,000 | 1,019,000 | 1,228,000 | 836,000 | 685,000 | 997,000 | 1,048,000 | 568,000 | 950,000 | 1,609,000 | 666,000 | 1,016,000 | 1,105,000 | 2,311,000 | 2,942,000 | 508,000 | 1,278,000 | 1,975,000 | 2,660,000 | 1,019,000 | 706,000 | 2,637,000 | 1,217,000 | 2,020,000 | 3,071,000 | 1,720,000 | 1,187,000 | 3,414,000 | 1,982,000 | 2,069,000 | 2,451,000 | 1,281,000 | 395,000 | 535,000 | 457,000 | 514,000 | 738,000 | 741,000 | 1,073,000 | 1,617,000 | 1,153,000 | 1,375,000 | 1,497,573 | 1,405,789 | 1,329,434 | 1,880,035 | 1,022,861 | 887,593 | 1,017,921 | 2,552,089 | 831,138 | 661,277 | 598,510 | 1,140,578 | 476,868 | 617,205 | 1,136,158 | 650,400 | 307,900 | 427,300 | 259,100 | 187,100 | 349,000 | 496,800 | 258,400 | 872,700 | 613,100 |
| accrued expenses | 28,424,000 | 25,456,000 | 33,842,000 | 28,204,000 | 18,594,000 | 17,536,000 | 22,029,000 | 18,471,000 | 12,257,000 | 9,374,000 | 12,835,000 | 11,425,000 | 11,229,000 | 9,234,000 | 12,000,000 | 10,253,000 | 7,851,000 | 7,023,000 | 8,459,000 | 8,007,000 | 6,467,000 | 5,648,000 | 6,419,000 | 5,410,000 | 5,474,000 | 9,614,000 | 12,256,000 | 14,897,000 | 17,845,000 | 21,275,000 | 19,424,000 | 13,233,000 | 14,937,000 | 18,431,000 | 19,623,000 | 21,879,000 | 15,420,000 | 17,703,000 | 17,897,000 | 14,966,000 | 13,807,000 | 9,904,000 | 9,692,000 | 8,157,000 | 6,555,000 | 6,359,000 | 5,966,000 | 4,416,000 | 4,200,000 | 4,178,000 | 4,134,000 | 3,810,000 | 4,402,000 | 3,024,000 | 4,358,929 | 8,794,887 | 10,485,405 | 5,341,231 | 3,038,941 | 3,215,922 | 2,603,581 | 2,674,544 | 2,624,701 | 3,084,537 | 2,857,507 | 2,334,708 | 2,891,573 | 2,720,799 | 3,237,668 | 3,028,800 | 2,764,100 | 2,132,100 | 2,396,200 | 2,153,700 | 1,904,100 | 2,118,600 | 3,120,200 | 2,414,300 | 2,814,500 |
| current portion of operating lease liabilities | 1,536,000 | 1,499,000 | 1,452,000 | 1,379,000 | 1,589,000 | 1,644,000 | 1,614,000 | 1,547,000 | 1,530,000 | 1,493,000 | 1,445,000 | 1,438,000 | 1,425,000 | 1,802,000 | 1,746,000 | 1,366,000 | 1,331,000 | 1,372,000 | 1,327,000 | 1,263,000 | 1,320,000 | 1,682,000 | 2,253,000 | 2,538,000 | 2,633,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of other long-term liabilities | 930,000 | 1,653,000 | 1,396,000 | 3,673,000 | 3,877,000 | 4,232,000 | 978,000 | 978,000 | 1,152,000 | 1,393,000 | 2,505,000 | 1,721,000 | 4,621,000 | 7,585,000 | 2,362,000 | 2,104,000 | 1,993,000 | 2,550,000 | 2,545,000 | 2,777,000 | 222,542 | 231,022 | 210,157 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total current liabilities | 32,963,000 | 32,018,000 | 39,501,000 | 32,093,000 | 27,658,000 | 26,291,000 | 31,125,000 | 27,836,000 | 15,646,000 | 15,219,000 | 18,610,000 | 16,287,000 | 29,949,000 | 14,560,000 | 16,528,000 | 14,176,000 | 14,488,000 | 16,977,000 | 14,206,000 | 12,200,000 | 10,841,000 | 10,932,000 | 11,888,000 | 11,509,000 | 11,989,000 | 16,851,000 | 19,982,000 | 24,012,000 | 24,915,000 | 28,788,000 | 27,024,000 | 18,630,000 | 20,003,000 | 25,307,000 | 23,635,000 | 26,691,000 | 21,148,000 | 21,614,000 | 21,202,000 | 19,507,000 | 16,795,000 | 12,503,000 | 18,330,000 | 15,131,000 | 12,579,000 | 12,546,000 | 10,778,000 | 10,409,000 | 8,920,000 | 23,281,000 | 23,714,000 | 24,824,000 | 14,107,000 | 12,856,000 | 14,051,943 | 18,424,329 | 20,155,865 | 11,478,937 | 8,762,104 | 8,465,337 | 10,207,668 | 10,084,313 | 8,231,463 | 6,595,344 | 6,513,153 | 3,692,743 | 3,585,612 | 3,576,729 | 4,597,834 | 3,812,100 | 3,329,300 | 2,941,200 | 3,165,500 | 3,863,500 | 3,788,300 | 3,623,000 | 5,026,600 | 4,959,800 | 5,175,300 |
| long-term portion of operating lease liabilities | 1,495,000 | 1,929,000 | 2,361,000 | 1,708,000 | 796,000 | 470,000 | 928,000 | 1,299,000 | 1,725,000 | 2,157,000 | 2,588,000 | 2,190,000 | 2,586,000 | 841,000 | 1,296,000 | 1,713,000 | 1,446,000 | 1,764,000 | 2,154,000 | 2,545,000 | 1,720,000 | 2,106,000 | 1,482,000 | 1,867,000 | 2,599,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other long-term liabilities | 2,543,000 | 2,543,000 | 3,473,000 | 3,473,000 | 3,473,000 | 3,473,000 | 4,403,000 | 4,403,000 | 4,403,000 | 4,403,000 | 5,333,000 | 5,333,000 | 5,333,000 | 10,539,000 | 7,354,000 | 7,600,000 | 6,335,000 | 6,158,000 | 10,121,000 | 11,050,000 | 10,396,000 | 15,763,000 | 17,091,000 | 19,242,000 | 20,296,000 | 23,302,000 | 30,348,000 | 33,282,000 | 75,351,000 | 85,826,000 | 85,188,000 | 16,225,000 | 16,494,000 | 16,592,000 | 10,370,000 | 10,648,000 | 11,000,000 | 10,679,000 | 11,075,000 | 7,346,000 | 7,415,000 | 6,636,000 | 6,668,000 | 6,365,000 | 6,394,000 | 6,418,000 | 5,981,000 | 5,994,000 | 6,002,000 | 5,587,000 | 5,798,000 | 6,024,000 | 989,000 | 1,026,000 | 1,054,323 | 4,702,491 | 4,815,954 | 4,516,433 | 4,165,126 | 3,089,611 | 2,323,785 | 2,004,333 | 1,870,051 | ||||||||||||||||
| total liabilities | 37,001,000 | 36,490,000 | 45,335,000 | 37,274,000 | 31,927,000 | 30,234,000 | 36,456,000 | 33,538,000 | 21,774,000 | 21,779,000 | 26,531,000 | 23,810,000 | 37,868,000 | 25,940,000 | 25,178,000 | 23,489,000 | 22,269,000 | 24,899,000 | 26,481,000 | 25,795,000 | 22,957,000 | 28,801,000 | 30,461,000 | 32,618,000 | 34,884,000 | 40,153,000 | 50,330,000 | 57,294,000 | 100,266,000 | 114,614,000 | 112,212,000 | 34,855,000 | 36,497,000 | 41,899,000 | 34,005,000 | 37,339,000 | 32,148,000 | 32,293,000 | 32,277,000 | 26,853,000 | 24,210,000 | 19,139,000 | 29,424,000 | 28,822,000 | 27,581,000 | 28,854,000 | 27,774,000 | 26,471,000 | 26,619,000 | 59,788,000 | 61,569,000 | 63,986,000 | 50,342,000 | 50,109,000 | 51,692,636 | ||||||||||||||||||||||||
| commitments and contingent liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2025 and december 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| common stock | 66,000 | 66,000 | 66,000 | 66,000 | 66,000 | 66,000 | 56,000 | 47,000 | 47,000 | 47,000 | 47,000 | 47,000 | 47,000 | 47,000 | 47,000 | 47,000 | 40,000 | 40,000 | 40,000 | 40,000 | 39,000 | 18,000 | 16,000 | 15,000 | 13,000 | 169,000 | 157,000 | 143,000 | 132,000 | 127,000 | 124,000 | 101,000 | 99,000 | 99,000 | 99,000 | 99,000 | 98,000 | 89,000 | 89,000 | 89,000 | 81,000 | 81,000 | 81,000 | 61,000 | 59,000 | 59,000 | 44,000 | 44,000 | 32,000 | 32,000 | 32,000 | 32,000 | 16,000 | 16,000 | 15,821 | 15,708 | 15,708 | 14,927 | 74,408 | 74,404 | 74,404 | 74,403 | 74,403 | 74,397 | 74,393 | 74,387 | 74,381 | 74,353 | 74,353 | 74,300 | 74,300 | 74,300 | 60,500 | 60,500 | 60,500 | 60,500 | 57,400 | ||
| additional paid-in capital | 2,317,621,000 | 2,308,367,000 | 2,298,849,000 | 2,288,683,000 | 2,277,824,000 | 2,266,472,000 | 1,823,168,000 | 1,598,591,000 | 1,591,213,000 | 1,585,863,000 | 1,580,829,000 | 1,574,926,000 | 1,568,124,000 | 1,564,599,000 | 1,561,142,000 | 1,557,576,000 | 1,282,657,000 | 1,281,173,000 | 1,279,824,000 | 1,278,523,000 | 1,272,783,000 | 1,107,029,000 | 1,101,598,000 | 1,098,429,000 | 1,089,755,000 | 1,078,419,000 | 1,071,092,000 | 1,060,768,000 | 1,025,108,000 | 1,011,066,000 | 998,897,000 | 901,560,000 | 889,468,000 | 882,875,000 | 874,240,000 | 869,635,000 | 866,771,000 | 668,596,000 | 666,334,000 | 664,669,000 | 477,595,000 | 474,942,000 | 473,632,000 | 335,501,000 | 324,062,000 | 323,587,000 | 270,250,000 | 269,689,000 | 233,259,000 | 232,061,000 | 231,093,000 | 230,020,000 | 139,882,000 | 139,253,000 | 138,033,698 | 134,948,606 | 133,101,784 | 121,418,956 | 258,838,046 | 258,737,723 | 258,661,233 | 258,560,628 | 257,887,168 | 257,465,806 | 257,185,249 | 258,139,855 | 258,134,160 | 257,832,304 | 257,832,304 | 256,991,800 | 256,955,400 | 256,945,000 | 233,708,000 | 223,326,300 | 223,326,300 | 223,323,000 | 223,316,800 | 209,700,500 | 209,642,100 |
| accumulated other comprehensive income | 3,339,000 | 3,568,000 | 3,314,000 | 5,288,000 | 1,780,000 | 2,244,000 | 3,308,000 | 2,135,000 | 2,072,000 | 2,123,000 | 1,260,000 | -112,000 | -417,000 | 112,000 | 1,894,000 | 2,548,000 | 2,592,000 | 2,587,000 | 2,589,000 | 2,608,000 | 2,594,000 | 2,597,000 | 2,635,000 | 2,638,000 | 2,602,000 | 2,582,000 | 2,590,000 | 2,559,000 | 2,588,000 | 2,577,000 | 2,562,000 | 2,610,000 | 2,723,000 | 2,687,000 | 2,560,000 | 2,436,000 | 2,616,000 | 2,624,000 | 2,748,000 | 2,670,000 | 2,686,000 | 2,548,000 | 2,689,000 | 2,775,000 | 2,722,000 | 2,762,000 | 2,654,000 | 2,774,000 | 2,760,000 | 2,796,000 | 2,658,000 | 2,663,000 | 2,593,000 | 2,591,000 | 2,593,577 | 2,569,211 | 2,355,330 | 2,508,206 | |||||||||||||||||||||
| accumulated deficit | -1,665,620,000 | -1,609,020,000 | -1,555,224,000 | -1,508,132,000 | -1,466,011,000 | -1,430,169,000 | -1,397,361,000 | -1,354,055,000 | -1,315,795,000 | -1,285,293,000 | -1,255,932,000 | -1,229,445,000 | -1,202,661,000 | -1,166,657,000 | -1,143,607,000 | -1,123,459,000 | -1,103,007,000 | -1,089,634,000 | -1,073,096,000 | -1,051,196,000 | -1,036,972,000 | -1,025,941,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders’ equity | 655,406,000 | 702,981,000 | 747,005,000 | 785,905,000 | 813,659,000 | 838,613,000 | 429,171,000 | 246,718,000 | 277,537,000 | 302,740,000 | 326,204,000 | 345,416,000 | 365,093,000 | 398,101,000 | 419,476,000 | 436,712,000 | 182,282,000 | 194,166,000 | 209,357,000 | 229,975,000 | 238,444,000 | 83,703,000 | 101,380,000 | 109,626,000 | 112,693,000 | 128,134,000 | 128,047,000 | 134,082,000 | 219,152,000 | 231,457,000 | 247,836,000 | 217,092,000 | 234,709,000 | 260,032,000 | 318,627,000 | 345,878,000 | 375,552,000 | 239,372,000 | 265,315,000 | 291,846,000 | 156,745,000 | 177,094,000 | 194,941,000 | 91,015,000 | 94,548,000 | 107,886,000 | 80,674,000 | 92,005,000 | 65,785,000 | 52,021,000 | 60,002,000 | 68,459,000 | 4,303,000 | 11,790,201 | 23,837,728 | 29,433,183 | 28,162,960 | 2,160,980 | 7,699,595 | 12,798,794 | 18,188,534 | 20,889,123 | 24,688,120 | 29,049,669 | 33,662,609 | 41,979,000 | 45,570,800 | 49,390,200 | 31,923,400 | 24,711,000 | 27,899,800 | 34,912,900 | 40,390,300 | ||||||
| total liabilities and stockholders’ equity | 692,407,000 | 739,471,000 | 792,340,000 | 823,179,000 | 845,586,000 | 868,847,000 | 465,627,000 | 280,256,000 | 299,311,000 | 324,519,000 | 352,735,000 | 369,226,000 | 402,961,000 | 424,041,000 | 444,654,000 | 460,201,000 | 204,551,000 | 219,065,000 | 235,838,000 | 255,770,000 | 261,401,000 | 112,504,000 | 131,841,000 | 142,244,000 | 147,577,000 | 168,287,000 | 178,377,000 | 191,376,000 | 319,418,000 | 346,071,000 | 360,048,000 | 251,947,000 | 271,206,000 | 301,931,000 | 352,632,000 | 383,217,000 | 407,700,000 | 271,665,000 | 297,592,000 | 318,699,000 | 180,955,000 | 196,233,000 | 224,365,000 | 119,837,000 | 122,129,000 | 136,740,000 | 108,448,000 | 118,476,000 | 92,404,000 | 111,809,000 | 121,571,000 | 132,445,000 | 48,102,000 | 54,412,000 | 63,482,837 | 79,185,535 | 86,342,637 | 40,803,760 | 43,404,629 | 49,209,200 | 54,343,763 | 61,479,542 | 64,054,284 | 68,548,612 | 73,308,236 | 36,451,917 | 40,064,284 | 44,478,284 | 74,133,999 | 46,113,800 | 48,900,100 | 52,331,400 | 35,171,800 | 28,781,900 | 32,019,900 | 38,689,900 | 47,725,400 | ||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2025 and december 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of long-term liabilities | 942,000 | 3,988,000 | 990,000 | 1,554,000 | 3,372,000 | 4,926,000 | 4,784,000 | 8,607,000 | 5,792,000 | 5,538,000 | 4,940,000 | 4,378,000 | 4,360,000 | 4,239,000 | 2,795,000 | 2,792,000 | 2,657,000 | 2,191,000 | 2,118,000 | 1,127,000 | 1,006,000 | 530,000 | 557,000 | 399,000 | 335,000 | 358,000 | 264,000 | 479,000 | 649,000 | 1,076,000 | 1,174,000 | 2,387,000 | 229,000 | 221,000 | 213,464 | 577,630 | 575,714 | 546,479 | 477,606 | 217,457 | 204,674 | 213,727 | 186,509 | ||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at december 31, 2024 and 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at december 31, 2023 and 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2023 and december 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2023 and december 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2023 and december 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at december 31, 2022 and 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2022 and december 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| litigation settlement payable | 15,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2022 and december 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2022 and december 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at december 31, 2021 and 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2021 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2021 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2021 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at december 31, 2020 and 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2020 and december 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2020 and december 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2020 and december 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2019 and december 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2019 and december 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2019 and december 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| goodwill | 90,976,000 | 90,976,000 | 90,976,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 8,965,000 | 1,036,285 | 1,036,285 | 1,036,285 | 1,036,285 | 1,036,285 | 1,036,285 | 1,036,285 | 1,036,285 | 1,036,285 | 1,036,285 | 1,036,285 | 1,036,300 | 1,036,300 | 1,036,300 | 1,036,300 | 1,036,300 | 1,036,300 | 1,036,300 | 1,036,300 | ||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2018 and december 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2018 and december 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2018 and december 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2017 and december 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2017 and december 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2017 and december 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2016 and december 31, 2015 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2016 and december 31, 2015 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2016 and december 31, 2015 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2015 and december 31, 2014 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2015 and december 31, 2014 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2015 and december 31, 2014 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2014 and december 31, 2013 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2014 and december 31, 2013 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2014 and december 31, 2013 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of term loan | 5,630,000 | 5,294,000 | 5,294,000 | 5,294,000 | 4,091,000 | 5,000,000 | 3,333,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| term loan, less current portion | 4,426,000 | 7,326,000 | 8,608,000 | 9,890,000 | 11,015,000 | 10,068,000 | 11,697,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2013 and december 31, 2012 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2013 and december 31, 2012 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2013 and december 31, 2012 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2012 and december 31, 2011 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2012 and december 31, 2011 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2012 and december 31, 2011 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible subordinated debt | 12,230,000 | 12,048,000 | 11,866,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2011 and december 31, 2010 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2011 and december 31, 2010 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2011 and december 31, 2010 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of deferred revenue | 5,056,000 | 5,285,000 | 5,144,000 | 5,366,000 | 5,279,000 | 5,024,729 | 5,043,160 | 5,132,279 | 1,093,324 | 4,122,672 | 3,786,108 | 6,039,687 | 4,380,074 | 4,553,082 | 2,618,508 | 2,846,981 | 12,497 | 24,998 | 37,499 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue | 30,920,000 | 32,057,000 | 33,138,000 | 35,246,000 | 36,227,000 | 36,586,370 | 35,924,641 | 35,724,564 | 103,215 | 43,886,636 | 44,759,405 | 42,984,354 | 45,069,123 | 45,033,615 | 46,830,689 | 46,602,216 | 10,000,000 | 10,000,000 | 10,000,000 | 132,900 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2010 and december 31, 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2010 and december 31, 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2010 and december 31, 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| payable due medarex | 2,957,000 | 2,957,000 | 2,957,248 | 2,957,248 | 2,987,528 | 2,945,050 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ (deficit) equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at september 30, 2009 and december 31, 2008 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders’ (deficit) equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at june 30, 2009 and december 31, 2008 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, .01 par value; 3,000,000 shares authorized; no shares issued and outstanding at march 31, 2009 and december 31, 2008 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| prepaid expenses and other current assets | 1,381,674 | 15,107,934 | 11,082,306 | 515,118 | 1,317,116 | 1,112,149 | 927,199 | 787,928 | 777,760 | 750,714 | 583,141 | 668,745 | 770,700 | 290,300 | 629,700 | 714,900 | 465,100 | 536,500 | 706,300 | 421,200 | 863,000 | 1,057,300 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of deferred rent | 57,447 | 57,447 | 57,447 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of loans payable | 165,798 | 163,772 | 161,850 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred rent | 211,977 | 181,400 | 150,823 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| loans payable | 786,860 | 847,625 | 907,825 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, 3,000,000 shares authorized; none issued and outstanding at september 30, 2008 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, 1.00 par value; 1,000,000 shares authorized; none issued and outstanding at december 31, 2007 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| class a common stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| investment in select vaccines ltd | 340,580 | 487,624 | 576,905 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, 3,000,000 shares authorized; none issued and outstanding at june 30, 2008 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, 3,000,000 shares authorized; none issued and outstanding at march 31, 2008 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| intangible and other assets | 3,338,362 | 3,591,866 | 3,831,914 | 4,071,963 | 4,320,740 | 4,569,518 | 4,818,296 | 5,067,073 | 5,315,851 | 5,564,629 | 5,813,407 | 6,311,000 | 6,549,500 | 6,798,200 | 8,380,800 | 8,641,900 | 8,948,200 | 7,470,800 | 7,897,800 | 9,581,800 | 9,955,300 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, 4,513,102 shares authorized; none issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| less: 220,319 common treasury shares at cost | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable | 102,437 | 238,606 | 320,941 | 554,358 | 735,671 | 716,219 | 418,380 | 5,643,420 | 5,477,071 | 916,451 | 615,800 | 540,100 | 1,652,600 | 568,500 | 585,800 | 634,500 | 2,124,300 | 227,500 | 161,500 | 383,500 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| investment in select vaccines ltd. | 696,951 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income: unrealized loss | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, 4,513,102 shares authorized; none issued and outstanding at december 31, 2006 and 2005 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred compensation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| less: 220,319 common treasury shares at cost at december 31, 2006 and 2005 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, 4,513,102 shares authorized; none issued and outstanding at december 31, 2005 and 2004 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| less: 220,319 common treasury shares at cost at december 31, 2005 and 2004 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term liabilities | 1,790,552 | 1,851,886 | 1,914,001 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| note payable | 342,700 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, 4,513,102 shares authorized; none issued and outstanding at september 30, 2004 and december 31, 2003 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| less: 220,300 common treasury shares at cost at september 30, 2004 and december 31, 2003 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion deferred revenue | 257,300 | 381,800 | 510,200 | 1,522,700 | 1,535,200 | 1,007,600 | 1,648,000 | 1,623,000 | 1,622,900 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, 4,513,102 shares authorized;none issued and outstanding at june 30, 2004 and december 31, 2003 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| less: 220,300 common treasury shares at cost at june 30, 2004 and december 31, 2003 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, 4,513,102 shares authorized; none issued and outstanding at march 31, 2004 and december 31, 2003 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| less: 220,300 common treasury shares at cost at march 31, 2004 and december 31, 2003 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term deferred revenue | 82,900 | 207,400 | 331,800 | 154,000 | 2,308,500 | 3,078,300 | 3,463,200 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| outstanding at september 30, 2003 and 60,464,900 issued and 60,332,300 outstanding at december 31, 2002 | 64,900 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| less: 220,300 and 132,600 common treasury shares at cost at september 30, 2003 and december 31, 2002 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| less: 220,300 and 132,600 common treasury shares at cost at june 30, 2003 and december 31, 2002 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| less: 215,300 and 132,600 common treasury shares at cost at march 31, 2003 and december 31, 2002 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| inventories | 59,400 | 78,900 | 84,900 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| less: 40,700 common treasury shares at cost at september 30, 2002 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion lease receivable | 71,900 | 179,900 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liabilities and stockholders' equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion lease payable | 49,800 | 124,800 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders' equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders' equity | 38,539,900 | 44,705,500 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities and stockholders' equity | 46,578,000 | 53,344,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
We provide you with 20 years of balance sheets for Celldex Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Celldex Therapeutics. Explore the full financial landscape of Celldex Therapeutics stock with our expertly curated balance sheets.
The information provided in this report about Celldex Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.